Academia Sinica
Taiwan, Province of China
The scientist’s investigation covers issues in Signal transduction, Cell biology, Receptor, Molecular biology and Toll-like receptor. Ruey-Bing Yang focuses mostly in the field of Signal transduction, narrowing it down to topics relating to Cancer research and, in certain cases, Metastasis, Breast carcinoma, Small hairpin RNA and Metastatic breast cancer. His Cell biology study combines topics from a wide range of disciplines, such as Cyclase activity, Cyclase, Biochemistry, Immunology and Innate immune system.
His study in the fields of Adenylyl cyclase under the domain of Receptor overlaps with other disciplines such as Fibroblast growth factor receptor 4, P2Y receptor and P2Y12. His Molecular biology study combines topics in areas such as Epidermal growth factor, Angiogenesis, Gene expression, Complementary DNA and Endothelium. The concepts of his Toll-like receptor study are interwoven with issues in Inflammation and TLR2.
Ruey-Bing Yang focuses on Molecular biology, Cell biology, Receptor, Internal medicine and Cancer research. His work carried out in the field of Molecular biology brings together such families of science as Epidermal growth factor, Messenger RNA and Sperm, Acrosome, Gamete. He has included themes like Epithelial–mesenchymal transition, Toll-like receptor, Bioinformatics and Osteoblast in his Cell biology study.
His study connects Signal transduction and Receptor. Ruey-Bing Yang usually deals with Internal medicine and limits it to topics linked to Endocrinology and Extracellular, Transgene and Kinase. His Cancer research research incorporates themes from Tumor necrosis factor alpha, Cell growth, Metastasis, Acute kidney injury and Breast cancer.
Ruey-Bing Yang mostly deals with Cancer research, Receptor, Growth factor, Molecular biology and Cell biology. His biological study spans a wide range of topics, including Inflammation, Downregulation and upregulation, Epidermal growth factor receptor and Tumor necrosis factor alpha. His Receptor research is multidisciplinary, incorporating elements of Endocrinology, Heterologous expression, Bone morphogenetic protein and Bone morphogenetic protein 2.
His work carried out in the field of Growth factor brings together such families of science as Thrombin and Thromboxane A2. His Molecular biology research is multidisciplinary, relying on both Platelet activation, Platelet, Epidermal growth factor and Thrombus. He combines subjects such as Phenotype, Vascular endothelial growth factor and Kinase insert domain receptor with his study of Cell biology.
Ruey-Bing Yang mainly investigates Cell biology, Internal medicine, Heterologous expression, Olfaction and Corticosterone. His Cell biology study incorporates themes from Vascular endothelial growth factor, VEGF receptors and Tumor angiogenesis. His work on Receptor and Transmembrane protein as part of general Internal medicine study is frequently linked to Grueneberg ganglion, therefore connecting diverse disciplines of science.
His Heterologous expression study frequently involves adjacent topics like Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
Hans D. Brightbill;Daniel H. Libraty;Stephan R. Krutzik;Ruey Bing Yang.
Science (1999)
Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2
Antonios O. Aliprantis;Ruey-Bing Yang;Melanie R. Mark;Shelly Suggett.
Science (1999)
Identification of the platelet ADP receptor targeted by antithrombotic drugs.
Gunther Hollopeter;Hans-Michael Jantzen;Diana Vincent;Georgia Li.
Nature (2001)
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
Ruey-Bing Yang;Melanie R. Mark;Alane Gray;Arthur Huang.
Nature (1998)
The apoptotic signaling pathway activated by Toll-like receptor-2.
Antonios O. Aliprantis;Ruey‐Bing Yang;David S. Weiss;Paul Godowski.
The EMBO Journal (2000)
Signaling Events Induced by Lipopolysaccharide-Activated Toll-Like Receptor 2
Ruey-Bing Yang;Melanie R. Mark;Austin L. Gurney;Paul J. Godowski.
Journal of Immunology (1999)
A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons.
Hans-Jurgen Fulle;Robert Vassar;David C. Foster;Ruey-Bing Yang.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Two membrane forms of guanylyl cyclase found in the eye.
Ruey-Bing Yang;David C. Foster;David L. Garbers;Hans-Jurgen Fulle.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Mutations in the Retinal Guanylate Cyclase (RETGC-1) Gene in Dominant Cone-Rod Dystrophy
Rosemary E. Kelsell;Kevin Gregory-Evans;Annette M. Payne;Isabelle Perrault.
Human Molecular Genetics (1998)
Disruption of a Retinal Guanylyl Cyclase Gene Leads to Cone-Specific Dystrophy and Paradoxical Rod Behavior
Ruey Bing Yang;Susan W. Robinson;Wei Hong Xiong;King Wai Yau.
The Journal of Neuroscience (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
The University of Texas Southwestern Medical Center
Genentech
Gilead Sciences
University of Hohenheim
Academia Sinica
University of Minnesota
Ludwig-Maximilians-Universität München
Leiden University Medical Center
University of Minnesota
Leiden University Medical Center
St Petersburg University
University of New South Wales
Shaanxi Normal University
Ehime University
Carnegie Mellon University
University of Oklahoma
Korea University
Rutgers, The State University of New Jersey
Stanford University
Harvard University
Michigan State University
University of New South Wales
Brigham and Women's Hospital
University of Montpellier
Memorial Sloan Kettering Cancer Center
Max Planck Society